A fixed-scope, fixed-price protocol. Each phase has a single tangible deliverable and a clear go / no-go gate, so you’re never committed beyond the next milestone.
Strategic intake, market positioning, target claims, regulatory scope (TGA/FDA/EU), and exclusion criteria. Deliverable: signed brief and feasibility memo.
Ingredient long-list, evidence grading, dosage modelling, sensory architecture, and a draft formulation matrix with rationale per actives slot.
Bench-prep, stability cycling, micro & sensory panels, accelerated aging, and where applicable, in-vivo or clinical pilot coordination.
A complete, manufacturer-agnostic dossier — formula, batch records, COA templates, regulatory file, and IP assignment in your name.